| 參考文獻 |
Akao, Y., Nakagawa, Y., and Akiyama, K. (1999). Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro. FEBS Lett. 455, 59-62.
Alexander, J. S., Minagar, A., Harper, M., Robinson-Jackson, S., Jennings, M., and Smith, S. J. (2007). Proteomic analysis of human cerebral endothelial cells activated by multiple sclerosis serum and IFNbeta-1b. J. Mol. Neurosci. 32, 169-178.
Anastasiou, D., Poulogiannis, G., Asara, J. M., Boxer, M. B., Jiang, J. K., Shen, M., Bellinger, G., Sasaki, A. T., Locasale, J. W., Auld, D. S., Thomas, C. J., Vander Heiden, M. G., and Cantley, L. C. (2011). Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334, 1278-1283.
Aposhian, H. V. (1989). Biochemical toxicology of arsenic. Rev. Biochem. Toxicol. 10, 265-299.
Aposhian, H. V., and Aposhian, M. M. (1989). Newer developments in arsenic toxicity. J. Am. Coll. Toxicol. 8, 1297-1305.
Bachleitner-Hofmann, T., Gisslinger, B., Grumbeck, E., and Gisslinger, H. (2001). Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia? Br. J. Haematol. 112, 783-786.
Barondes, S. H., Cooper, D. N., Gitt, M. A., and Leffler, H. (1994). Galectins. Structure and function of a large family of animal lectins. J. Biol. Chem. 269, 20807-20810.
Barrett, M. P., and Fairlamb, A. H. (1999). The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes. Parasitol. Today 15, 136-140.
Benvenuto, G., Carpentieri, M. L., Salvatore, P., Cindolo, L., Bruni, C. B., and Chiariotti, L. (1996). Cell-specific transcriptional regulation and reactivation of galectin-1 gene expression are controlled by DNA methylation of the promoter region. Mol. Cell Biol. 16, 2736-2743.
Bertolero, F., Pozzi, G., Sabbioni, E., and Saffiotti, U. (1987). Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation. Carcinogenesis 8, 803-808.
Bhattacharjee, H., Li, J., Ksenzenko, M. Y., and Rosen, B. P. (1995). Role of cysteinyl residues in metalloactivation of the oxyanion-translocating ArsA ATPase. J. Biol. Chem. 270, 11245-11250.
Bhattacharjee, H., and Rosen, B. P. (1996). Spatial proximity of Cys113, Cys172, and Cys422 in the metalloactivation domain of the ArsA ATPase. J. Biol. Chem. 271, 24465-24470.
Bode, A. M., and Dong, Z. (2002). The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Crit. Rev. Oncol. Hematol. 42, 5-24.
Bogdan, G. M., Sampayo-Reyes, A., and Aposhian, H. V. (1994). Arsenic binding proteins of mammalian systems: I. Isolation of three arsenite-binding proteins of rabbit liver. Toxicology 93, 175-93.
Boquist, L., Boquist, S., and Ericsson, I. (1988). Structural beta-cell changes and transient hyperglycemia in mice treated with compounds inducing inhibited citric acid cycle enzyme activity. Diabetes 37, 89-98.
Brown, K. G., Boyle, K. E., Chen, C. W., and Gibb, H. J. (1989). A dose-response analysis of skin cancer from inorganic arsenic in drinking water. Risk Anal. 9, 519-528.
Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820.
Bryk, R., Griffin, P., and Nathan, C. (2000). Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407, 211-215.
Buchet, J. P., Lauwerys, R., and Roels, H. (1981). Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int. Arch. Occup. Environ. Health 48, 71-79.
Camby, I., Le Mercier, M., Lefranc, F., and Kiss, R. (2006). Galectin-1: a small protein with major functions. Glycobiology 16, 137R-157R.
Carlson-Lynch, H., Beck, B. D., and Boardman, P. D. (1994). Arsenic risk assessment. Environ. Health Perspect. 102, 354-356.
Carter, D. E., Aposhian, H. V., and Gandolfi, A. J. (2003). The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review. Toxicol. Appl. Pharmacol. 193, 309-334.
Chang, K. N., Lee, T. C., Tam, M. F., Chen, Y. C., Lee, L. W., Lee, S. Y., Lin, P. J., and Huang, R. N. (2003). Identification of galectin I and thioredoxin peroxidase II as two arsenic-binding proteins in Chinese hamster ovary cells. Biochem. J. 371, 495-503.
Chang, Y. Y., Chiang, M. C., Kuo, T. C., Chi, L. L., Kao, Y. H., and Huang, R. N. (2011). The down-regulation of galectin-1 expression is a specific biomarker of arsenic toxicity. Toxicol. Lett. 205, 38-46.
Chen, C. J., Chuang, Y. C., You, S. L., Lin, T. M., and Wu, H. Y. (1986). A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br. J. Cancer. 53, 399-405.
Chen, C. J., Wu, M. M., Lee, S. S., Wang, J. D., Cheng, S. H., and Wu, H. Y. (1988). Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis 8, 452-460.
Chen, G. Q., Shi, X. G., Tang, W., Xiong, S. M., Zhu, J., Cai, X., Han, Z. G., Ni, J. H., Shi, G. Y., Jia, P. M., Liu, M. M., He, K. L., Niu, C., Ma, J., Zhang, P., Zhang, T. D., Paul, P., Naoe, T., Kitamura, K., Miller, W., Waxman, S., Wang, Z. Y., de The, H., Chen, S. J., and Chen, Z. (1997). Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood 89, 3345-3353.
Chen, G. Q., Zhu, J., Shi, X. G., Ni, J. H., Zhong, H. J., Si, G. Y., Jin, X. L., Tang, W., Li, X. S., Xong, S. M., Shen, Z. X., Sun, G. L., J., M., Zhang, P., Zhang, T. D., Gazin, C., Naoe, T., Chen, S. J., Wang, Z. Y., and Chen, Z. (1996). In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 88, 1052-1061.
Choi, Y. J., Park, J. W., Suh, S. I., Mun, K. C., Bae, J. H., Song, D. K., Kim, S. P., and Kwon, T. K. (2002). Arsenic trioxide-induced apoptosis in U937 cells involve generation of reactive oxygen species and inhibition of Akt. Int. J. Oncol. 21, 603-610.
Crete, P., and Landry, J. (1990). Induction of HSP27 phosphorylation and thermoresistance in Chinese hamster cells by arsenite, cycloheximide, A23187, and EGTA. Radiat. Res. 121, 320-327.
Cui, X., Kobayashi, Y., Akashi, M., and Okayasu, R. (2008). Metabolism and the paradoxical effects of arsenic: carcinogenesis and anticancer. Curr. Med. Chem. 15, 2293-2304.
Cullen, W. R., and Reimer, K. J. (1989). Arsenic speciation in the environment. Chem. Rev. 89, 713-774.
Del Razo, L. M., Arellano, M. A., and Cebrian, M. E. (1990). The oxidation states of arsenic in well-water from a chronic arsenicism area of northern Mexico. Environ. Pollut. 64, 143-153.
Delnomdedieu, M., Basti, M. M., Otvos, J. D., and Thomas, D. J. (1993). Transfer of arsenite from glutathione to dithiols: a model of interaction. Chem. Res. Toxicol. 6, 598-602.
Delnomdedieu, M., Basti, M. M., Styblo, M., Otvos, J. D., and Thomas, D. J. (1994). Complexation of arsenic species in rabbit erythrocytes. Chem. Res. Toxicol. 7, 621-627.
Dey, S., Papadopoulou, B., Haimeur, A., Roy, G., Grondin, K., Dou, D., Rosen, B. P., and Ouellette, M. (1994). High level arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system. Mol. Biochem. Parasitol. 67, 49-57.
Diaz-Latoud, C., Buache, E., Javouhey, E., and Arrigo, A. P. (2005). Substitution of the unique cysteine residue of murine Hsp25 interferes with the protective activity of this stress protein through inhibition of dimer formation. Antioxid. Redox Signal. 7, 436-445.
Du, X. L., Edelstein, D., Rossetti, L., Fantus, I. G., Goldberg, H., Ziyadeh, F., Wu, J., and Brownlee, M. (2000). Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl. Acad. Sci. USA 97, 12222-12226.
Dyson, H. J., and Wright, P. E. (1998). Equilibrium NMR studies of unfolded and partially folded proteins. Nat. Struct. Biol. 5 Suppl, 499-503.
Elola, M. T., Chiesa, M. E., Alberti, A. F., Mordoh, J., and Fink, N. E. (2005). Galectin-1 receptors in different cell types. J. Biomed. Sci. 12, 13-29.
Fischer, A. B., Buchet, J. P., and Lauwerys, R. R. (1985). Arsenic uptake, cytotoxicity and detoxification studied in mammalian cells in culture. Arch. Toxicol. 57, 168-172.
Flora, S. J. (2011). Arsenic-induced oxidative stress and its reversibility. Free Radic. Biol. Med. 51, 257-281.
Fuertes, M. B., Molinero, L. L., Toscano, M. A., Ilarregui, J. M., Rubinstein, N., Fainboim, L., Zwirner, N. W., and Rabinovich, G. A. (2004). Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase. Mol. Cell Biochem. 267, 177-185.
Gallagher, B. M., and Phelan, S. A. (2007). Investigating transcriptional regulation of Prdx6 in mouse liver cells. Free Radic. Biol. Med. 42, 1270-1277.
Ghosh, M., Shen, J., and Rosen, B. P. (1999). Pathways of As(III) detoxification in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 96, 5001-5006.
Gladysheva, T. B., Oden, K. L., and Rosen, B. P. (1994). Properties of the arsenate reductase of plasmid R773. Biochemistry 33, 7288-7293.
Grad, J. M., Bahlis, N. J., Reis, I., Oshiro, M. M., Dalton, W. S., and Boise, L. H. (2001). Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells. Blood 98, 805-813.
Gresser, M. J. (1981). ADP-arsenate, formation by submitochondrial particals under phosphorylating conditions. J. Biol. Chem. 256, 5981-5983.
Gurr, J. R., Liu, F., Lynn, S., and Jan, K. Y. (1998). Calcium-dependent nitric oxide production is involved in arsenite-induced micronuclei. Mutat. Res. 416, 137-148.
Hirabayashi, J., and Kasai, K. (1991). Effect of amino acid substitution by sited-directed mutagenesis on the carbohydrate recognition and stability of human 14-kDa beta-galactoside-binding lectin. J. Biol. Chem. 266, 23648-23653.
Hoffman, R. D., and Lane, M. D. (1992). Iodophenylarsine oxide and arsenical affinity chromatography: new probes for dithiol proteins. Application to tubulins and to components of the insulin receptor-glucose transporter signal transduction pathway. J. Biol. Chem. 267, 14005-14011.
Hofmann, B., Hecht, H. J., and Flohe, L. (2002). Peroxiredoxins. Biol. Chem. 383, 347-364.
Honore, B. (2009). The rapidly expanding CREC protein family: members, localization, function, and role in disease. Bioessays 31, 262-277.
Honore, B., and Vorum, H. (2000). The CREC family, a novel family of multiple EF-hand, low-affinity Ca(2+)-binding proteins localised to the secretory pathway of mammalian cells. FEBS Lett. 466, 11-18.
Horie, H., Kadoya, T., Hikawa, N., Sango, K., Inoue, H., Takeshita, K., Asawa, R., Hiroi, T., Sato, M., Yoshioka, T., and Ishikawa, Y. (2004). Oxidized galectin-1 stimulates macrophages to promote axonal regeneration in peripheral nerves after axotomy. J. Neurosci. 24, 1873-1880.
Huang, C. F., Chen, Y. W., Yang, C. Y., Tsai, K. S., Yang, R. S., and Liu, S. H. (2011). Arsenic and diabetes: current perspectives. Kaohsiung J. Med. Sci. 27, 402-410.
Huang, R. N., and Lee, T. C. (1996). Arsenite efflux is inhibited by verapamil, cyclosporin A, and GSH-depleting agents in arsenite-resistant Chinese hamster ovary cells. Toxicol. Appl. Pharmacol. 141, 17-22.
Hughes, R. C. (1999). Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim. Biophys. Acta. 1473, 172-185.
Iglesias, M. M., Rabinovich, G. A., Ivanovic, V., Sotomayor, C., and Wolfenstein-Todel, C. (1998). Galectin-1 from ovine placenta--amino-acid sequence, physicochemical properties and implications in T-cell death. Eur. J. Biochem. 252, 400-407.
Ishii, T., Yamada, M., Sato, H., Matsue, M., Taketani, S., Nakayama, K., Sugita, Y., and Bannai, S. (1993). Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein. J. Biol. Chem. 268, 18633-18636.
Iwahara, S., Satoh, H., Song, D. X., Webb, J., Burlingame, A. L., Nagae, Y., and Muller-Eberhard, U. (1995). Purification, characterization, and cloning of a heme-binding protein (23 kDa) in rat liver cytosol. Biochemistry 34, 13398-13406.
Ji, G., Garber, E. A., Armes, L. G., Chen, C. M., Fuchs, J. A., and Silver, S. (1994). Arsenate reductase of Staphylococcus aureus plasmid pI258. Biochemistry 33, 7294-7299.
Ji, G., and Silver, S. (1992). Regulation and expression of the arsenic resistance operon from Staphylococcus aureus plasmid pI258. J. Bacteriol. 174, 3684-3694.
Jing, H. M., Yukihiro, S., Ke, X. Y., Yoshiro, K., and Akiharu, W. (2002). Effect of arsenic trioxide on different cell lines derived from chronic myeloid leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 10, 413-418.
Kala, S. V., Neely, M. W., Kala, G., Prater, C. I., Atwood, D. W., Rice, J. S., and Lieberman, M. W. (2000). The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J. Biol. Chem. 275, 33404-33408.
Kalef, E., and Gitler, C. (1994). Purification of vicinal dithiol-containing proteins by arsenical-based affinity chromatography. Meth. Enzymol. 233, 395-403.
Kamiya, K., Cruse, W. B., and Kennard, O. (1983). The arsonomethyl group as an analogue of phosphate. An X-ray investigation. Biochem. J. 213, 217-223.
Kang, S. W., Baines, I. C., and Rhee, S. G. (1998). Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J. Biol. Chem. 273, 6303-6311.
Karkaria, C. E., Chen, C. M., and Rosen, B. P. (1990). Mutagenesis of a nucleotide-binding site of an anion-translocating ATPase. J. Biol. Chem. 265, 7832-7836.
Kaur, P., and Rosen, B. P. (1993). Complementation between nucleotide binding domains in an anion-translocating ATPase. J. Bacteriol. 175, 351-357.
Kaur, S., Kamli, M. R., and Ali, A. (2011). Role of arsenic and its resistance in nature. Can. J. Microbiol. 57, 769-774.
Kelly, S. M., Jess, T. J., and Price, N. C. (2005). How to study proteins by circular dichroism. Biochim. Biophys. Acta. 1751, 119-139.
Kenney, L. J., and Kaplan, J. H. (1988). Arsenate substitutes for phosphate in the human red cell sodium pump and anion exchanger. J. Biol. Chem. 263, 7954-7960.
Kitchin, K. T. (2001). Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172, 249-261.
Kitchin, K. T., and Wallace, K. (2005). Arsenite binding to synthetic peptides based on the Zn finger region and the estrogen binding region of the human estrogen receptor-alpha. Toxicol. Appl. Pharmacol. 206, 66-72.
Kitchin, K. T., and Wallace, K. (2006). Arsenite binding to synthetic peptides: the effect of increasing length between two cysteines. J. Biochem. Mol. Toxicol. 20, 35-38.
Kitchin, K. T., and Wallace, K. (2008). The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. J. Inorg. Biochem. 102, 532-539.
Lantz, R. C., Lynch, B. J., Boitano, S., Poplin, G. S., Littau, S., Tsaprailis, G., and Burgess, J. L. (2007). Pulmonary biomarkers based on alterations in protein expression after exposure to arsenic. Environ. Health Perspect. 115, 586-591.
Lau, A. T., He, Q. Y., and Chiu, J. F. (2004). A proteome analysis of the arsenite response in cultured lung cells: evidence for in vitro oxidative stress-induced apoptosis. Biochem. J. 382, 641-650.
Lee-Chen, S. F., Gurr, J. R., Lin, I. B., and Jan, K. Y. (1993). Arsenite enhances DNA double-strand breaks and cell killing of methyl methanesulfonate-treated cells by inhibiting the excision of alkali-labile sites. Mutat. Res. 294, 21-28.
Lee, T. C., and Ho, I. C. (1994). Expression of heme oxygenase in arsenic-resistant human lung adenocarcinoma cells. Cancer Res. 54, 1660-1664.
Lee, T. C., Huang, R. Y., and Jan, K. Y. (1985a). Sodium arsenite enhances the cytotoxicity, clastogenicity, and 6-thioguanine-resistant mutagenicity of ultraviolet light in Chinese hamster ovary cells. Mutat. Res. 148, 83-89.
Lee, T. C., Lee, K. C., Tzeng, Y. J., Huang, R. Y., and Jan, K. Y. (1986). Sodium arsenite potentiates the clastogenicity and mutagenicity of DNA crosslinking agents. Environ. Mutagen. 8, 119-128.
Lee, T. C., Oshimura, M., and Barrett, J. C. (1985b). Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effects in Syrian hamster embryo cells in culture. Carcinogenesis 6, 1421-1426.
Li, W., and Chou, I. N. (1992). Effects of sodium arsenite on the cytoskeleton and cellular glutathione levels in cultured cells. Toxicol. Appl. Pharmacol. 114, 132-139.
Liang, L., Tajmir-Riahi, H. A., and Subirade, M. (2008). Interaction of beta-lactoglobulin with resveratrol and its biological implications. Biomacromolecules 9, 50-56.
Liao, D. I., Kapadia, G., Ahmed, H., Vasta, G. R., and Herzberg, O. (1994). Structure of S-lectin, a developmentally regulated vertebrate beta-galactoside-binding protein. Proc. Natl. Acad. Sci. USA 91, 1428-1432.
Lin, C. H., Huang, C. F., Chen, W. Y., Chang, Y. Y., Ding, W. H., Lin, M. S., Wu, S. H., and Huang, R. N. (2006). Characterization of the interaction of galectin-1 with sodium arsenite. Chem. Res. Toxicol. 19, 469-474.
Liu, Y. C., and Huang, H. (1997). Involvement of calcium-dependent protein kinase C in arsenite-induced genotoxicity in Chinese hamster ovary cells. J. Cell Biochem. 64, 423-433.
Lo, J. F., Wang, H. F., Tam, M. F., and Lee, T. C. (1992). Glutathione S-transferase pi in an arsenic-resistant Chinese hamster ovary cell line. Biochem. J. 288, 977-982.
Lopez-Lucendo, M. F., Solis, D., Andre, S., Hirabayashi, J., Kasai, K., Kaltner, H., Gabius, H. J., and Romero, A. (2004). Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding. J. Mol. Biol. 343, 957-970.
Lynn, S., Lai, H. T., Gurr, J. R., and Jan, K. Y. (1997). Arsenite retards DNA break rejoining by inhibiting DNA ligation. Mutagenesis 12, 353-358.
Maeda, H., Hori, S., Nishitoh, H., Ichijo, H., Ogawa, O., Kakehi, Y., and Kakizuka, A. (2001). Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res. 61, 5432-5440.
Mandeville, J. S., Froehlich, E., and Tajmir-Riahi, H. A. (2009). Study of curcumin and genistein interactions with human serum albumin. J. Pharm. Biomed. Anal. 49, 468-474.
Manevich, Y., Feinstein, S. I., and Fisher, A. B. (2004). Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Proc. Natl. Acad. Sci. USA 101, 3780-3785.
Manevich, Y., and Fisher, A. B. (2005). Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic. Biol. Med. 38, 1422-1432.
Manevich, Y., Sweitzer, T., Pak, J. H., Feinstein, S. I., Muzykantov, V., and Fisher, A. B. (2002). 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage. Proc. Natl. Acad. Sci. USA 99, 11599-11604.
Mass, M. J., and Wang, L. (1997). Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat. Res. 386, 263-277.
Menzel, D. B., Hamadeh, H. K., Lee, E., Meacher, D. M., Said, V., Rasmussen, R. E., Greene, H., and Roth, R. N. (1999). Arsenic binding proteins from human lymphoblastoid cells. Toxicol. Lett. 105, 89-101.
Mitchell, R. A., Chang, B. F., Huang, C. H., and DeMaster, E. G. (1971). Inhibition of mitochrondrial energy-linked functions by arsenate, evidence for a nonhydrolytic mode of inhibition action. Biochemistry (Mosc) 10, 2049-2054.
Mizumura, A., Watanabe, T., Kobayashi, Y., and Hirano, S. (2010). Identification of arsenite-and arsenic diglutathione-binding proteins in human hepatocarcinoma cells. Toxicol. Appl. Pharmacol. 242, 119-125.
Mortz, E., Krogh, T. N., Vorum, H., and Gorg, A. (2001). Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 1, 1359-1363.
Nesmelova, I. V., Pang, M., Baum, L. G., and Mayo, K. H. (2008). 1H, 13C, and 15N backbone and side-chain chemical shift assignments for the 29 kDa human galectin-1 protein dimer. Biomol. NMR Assign. 2, 203-5.
Nickel, W. (2003). The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur. J. Biochem. 270, 2109-2119.
Ning, S., and Knox, S. J. (2004). Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide. Int. J. Radiat. Oncol. Biol. Phys. 60, 197-203.
Ning, S., and Knox, S. J. (2006). Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma. Int. J. Radiat. Oncol. Biol. Phys. 65, 493-498.
Ochi, T., Kaise, T., and Oya-Ohta, Y. (1994). Glutathione plays different roles in the induction of the cytotoxic effects of inorganic and organic arsenic compounds in cultured BALB/c 3T3 cells. Experientia 50, 115-120.
Oya-Ohta, Y., Kaise, T., and Ochi, T. (1996). Induction of chromosomal aberrations in cultured human fibroblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction. Mutat. Res. 357, 123-129.
Pace, K. E., Hahn, H. P., and Baum, L. G. (2003). Preparation of recombinant human galectin-1 and use in T-cell death assays. Methods Enzymol. 363, 499-518.
Papadopoulou, B., Roy, G., Dey, S., Rosen, B. P., and Ouellette, M. (1994). Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance. J. Biol. Chem. 269, 11980-11986.
Peshenko, I. V., and Shichi, H. (2001). Oxidation of active center cysteine of bovine 1-Cys peroxiredoxin to the cysteine sulfenic acid form by peroxide and peroxynitrite. Free Radic. Biol. Med. 31, 292-303.
Qian, Y., Castranova, V., and Shi, X. (2003). New perspectives in arsenic-induced cell signal transduction. J. Inorg. Biochem. 96, 271-278.
Rabinovich, G. A., Baum, L. G., Tinari, N., Paganelli, R., Natoli, C., Liu, F. T., and Iacobelli, S. (2002). Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol. 23, 313-320.
Rapoport, E. M., Kurmyshkina, O. V., and Bovin, N. V. (2008). Mammalian galectins: structure, carbohydrate specificity, and functions. Biochemistry (Mosc) 73, 393-405.
Reichl, F. X., Kreppel, H., Szinicz, L., Fichtl, B., and Forth, W. (1991). Effect of glucose treatment on carbohydrate content in various organs in mice after acute As2O3 poisoning. Vet. Hum. Toxicol. 33, 230-235.
Reichl, F. X., Szinicz, L., Kreppel, H., and Forth, W. (1988). Effect of arsenic on carbohydrate metabolism after single or repeated injection in guinea pigs. Arch. Toxicol. 62, 473-475.
Rojewski, M. T., Korper, S., and Schrezenmeier, H. (2004). Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to beside. Leuk. Lymphoma 45, 2387-2401.
Rosen, B. P. (2002). Biochemistry of arsenic detoxification. FEBS Lett. 529, 86-92.
Schinella, G. R., Tournier, H. A., Buschiazzo, H. O., and de Buschiazzo, P. M. (1996). Effect of arsenic (V) on the antioxidant defense system: in vitro oxidation of rat plasma lipoprotein. Pharmacol. Toxicol. 79, 293-296.
Schmidt, A. C., Fahlbusch, B., and Otto, M. (2009). Size exclusion chromatography coupled to electrospray ionization mass spectrometry for analysis and quantitative characterization of arsenic interactions with peptides and proteins. J. Mass Spectrom. 44, 898-910.
Scott, S. A., Scott, K., and Blanchard, H. (2007). Crystallization and preliminary crystallographic analysis of recombinant human galectin-1. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 63, 967-971.
Seol, J. G., Park, W. H., Kim, E. S., Jung, C. W., Hyun, J. M., Kim, B. K., and Lee, Y. Y. (1999). Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1. Biochem. Biophys. Res. Commun. 265, 400-404.
Shen, Y., Shen, Z. X., Yan, H., Chen, J., Zeng, X. Y., Li, J. M., Li, X. S., Wu, W., Xiong, S. M., Zhao, W. L., Tang, W., Wu, F., Liu, Y. F., Niu, C., Wang, Z. Y., Chen, S. J., and Chen, Z. (2001). Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage. Leukemia 15, 735-741.
Shi, W., Wu, J., and Rosen, B. P. (1994). Identification of a putative metal binding site in a new family of metalloregulatory proteins. J. Biol. Chem. 269, 19826-19829.
Shuvaeva, T. M., Novoselov, V. I., Fesenko, E. E., and Lipkin, V. M. (2009). Peroxiredoxins, a new family of antioxidant proteins. Bioorg. Khim. 35, 581-596.
Silver, S., Ji, G., Broer, S., Dey, S., Dou, D., and Rosen, B. P. (1993). Orphan enzyme or patriarch of a new tribe: the arsenic resistance ATPase of bacterial plasmids. Mol. Microbiol. 8, 637-642.
Smith, A. H., Hopenhayn-Rich, C., Bates, M. N., Goeden, H. M., Hertz-Picciotto, I., Duggan, H. M., Wood, R., Kosnett, M. J., and Smith, M. T. (1992). Cancer risks from arsenic in drinking water. Environ. Health Perspect. 97, 259-267.
Smith, A. H., Lingas, E. O., and Rahman, M. (2000). Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull. World Health Organ. 78, 1093-1103.
Sreerama, N., and Woody, R. W. (2004). On the analysis of membrane protein circular dichroism spectra. Protein Sci. 13, 100-112.
Styblo, M., Hughes, M. F., and Thomas, D. J. (1996). Liberation and analysis of protein-bound arsenicals. J. Chromatogr. B, Biomed. Appl. 677, 161-166.
Styblo, M., and Thomas, D. J. (1997). Binding of arsenicals to proteins in an in vitro methylation system. Toxicol. Appl. Pharmacol. 147, 1-8.
Styblo, M., Yamauchi, H., and Thomas, D. J. (1995). Comparative in vitro methylation of trivalent and pentavalent arsenicals. Toxicol. Appl. Pharmacol. 135, 172-178.
Sunderman, F. W. (1979). Mechanism of metal carcinogens. Biol. Trace Elem. Res. 1, 53-58.
Szinicz, L., and Forth, W. (1988). Effect of As2O3 on gluconeogenesis. Arch. Toxicol. 61, 444-449.
Tabocova, S., Hunter, E. S., 3rd, and Gladen, B. C. (1996). Developmental toxicity of inorganic arsenic in whole embryo: culture oxidation state, dose, time, and gestational age dependence. Toxicol. Appl. Pharmacol. 138, 298-307.
Thiel, T. (1988). Phosphate transport and arsenate resistance in the cyanobacterium Anabaena variabilis. J. Bacteriol. 170, 1143-1147.
Tracey, B. M., Feizi, T., Abbott, W. M., Carruthers, R. A., Green, B. N., and Lawson, A. M. (1992). Subunit molecular mass assignment of 14,654 Da to the soluble beta-galactoside-binding lectin from bovine heart muscle and demonstration of intramolecular disulfide bonding associated with oxidative inactivation. J. Biol. Chem. 267, 10342-10347.
Tsuji, A., Kikuchi, Y., Sato, Y., Koide, S., Yuasa, K., Nagahama, M., and Matsuda, Y. (2006). A proteomic approach reveals transient association of reticulocalbin-3, a novel member of the CREC family, with the precursor of subtilisin-like proprotein convertase, PACE4. Biochem. J. 396, 51-59.
Vahter, M., and Marafante, E. (1983). Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem. Biol. Interact. 47, 29-44.
Vahter, M., and Marafante, E. (1985). Reduction and binding of arsenate in marmoset monkeys. Arch. Toxicol. 57, 119-124.
Vahter, M., Marafante, E., Lindgren, A., and Dencker, L. (1982). Tissue distribution and subcellular binding of arsenic in marmoset mokeys after injection of 74As-arsenite. Arch. Toxicol. 51, 65-67.
Wang, H. F., and Lee, T. C. (1993). Glutathione S-transferase pi facilitates the excretion of arsenic from arsenic-resistant Chinese hamster ovary cells. Biochem. Biophys. Res. Commun. 192, 1093-1099.
Wang, T. C., Huang, J. S., Yang, V. C., Lan, H. J., Lin, C. J., and Jan, K. Y. (1994). Delay of the excision of UV light-induced DNA adducts is involved in the coclastogenicity of UV light plus arsenite. Int. J. Radiat. Biol. 66, 367-372.
Wang, T. S., Kuo, C. F., Jan, K. Y., and Huang, H. (1996). Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J. Cell Physiol. 169, 256-268.
Wang, Y., Feinstein, S. I., Manevich, Y., Ho, Y. S., and Fisher, A. B. (2004). Lung injury and mortality with hyperoxia are increased in peroxiredoxin 6 gene-targeted mice. Free Radic. Biol. Med. 37, 1736-1743.
Warner, M. L., Moore, L. E., Smith, M. T., Kalman, D. A., Fanning, E., and Smith, A. H. (1994). Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol. Biomarkers Prev. 3, 583-590.
Williamson, J. R., Chang, K., Frangos, M., Hasan, K. S., Ido, Y., Kawamura, T., Nyengaard, J. R., van den Enden, M., Kilo, C., and Tilton, R. G. (1993). Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42, 801-813.
Winski, S. L., and Carter, D. E. (1995). Interactions of rat red blood cell sulfhydryls with arsenate and arsenite. J. Toxicol. Environ. Health. 46, 379-397.
Wood, J. M. (1974). Biological cycles for toxic elements in the environment. Science 183, 1049-1052.
Yamanaka, K., Hasegawa, A., Sawamura, R., and Okada, S. (1989). Dimethylated arsenics induce DNA strand breaks in lung via the production of active oxygen in mice. Biochem. Biophys. Res. Commun. 165, 43-50.
Yamanaka, K., Hoshino, M., Okamoto, M., Sawamura, R., Hasegawa, A., and Okada, S. (1990). Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical. Biochem. Biophys. Res. Commun. 168, 58-64.
Yan, H., Wang, N., Weinfeld, M., Cullen, W. R., and Le, X. C. (2009). Identification of arsenic-binding proteins in human cells by affinity chromatography and mass spectrometry. Anal. Chem. 81, 4144-4152.
Zhang, T., Wang, S. S., Hong, L., Wang, X. L., and Qi, Q. H. (2003). Arsenic trioxide induces apoptosis of rat hepatocellular carcinoma cells in vivo. J. Exp. Clin. Cancer Res. 22, 61-68.
Zhang, T. C., Cao, E. H., Li, J. F., Ma, W., and Qin, J. F. (1999). Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide. Eur. J. Cancer 35, 1258-1263.
Zhang, X., Yang, F., Shim, J. Y., Kirk, K. L., Anderson, D. E., and Chen, X. (2007). Identification of arsenic-binding proteins in human breast cancer cells. Cancer Lett. 255, 95-106.
Zhou, L., Jing, Y., Styblo, M., Chen, Z., and Waxman, S. (2005). Glutathione-S-transferase pi inhibits As2O3-induced apoptosis in lymphoma cells: involvement of hydrogen peroxide catabolism. Blood 105, 1198-1203.
|
[Endnote RIS 格式]
[相關文章]
[文章引用]
[完整記錄]
[館藏目錄]
[檢視]
plurk
funp
live
udn
HD
myshare
netvibes
friend
youpush
delicious
baidu
Google bookmarks
del.icio.us
hemidemi
facebook
twitter
google
reddit